Physicians perceive that diuretics are less effective than other antihypertensive medications and that β-blockers are less tolerated. In addition, their willingness to prescribe β-blockers or ...

Current guideline recommendations for the use of beta-blockers after myocardial infarction without reduced ejection fraction are based on trials conducted before routine reperfusion, invasive care, ...

Objective: To evaluate the effects of patient copayment and coinsurance policies on adherence to therapy with β-adrenergic blocking agents (β-blockers) and on the rate of initiation of β-blocker ...

The evidence supporting beta-blocker therapy after myocardial infarction was established before the introduction of modern coronary reperfusion therapy and secondary prevention strategies. In an ...

Background: Based on a series of clinical trials showing no difference in the effectiveness or tolerability of most major classes of antihypertensive medications, the Joint National Commission on High ...